Accessibility links Skip to main content

“Train people well enough so they can leave. Treat them well enough so they don’t want to.

At Farma Consulting, we recognize that our employees are our most valuable asset. In line with our vision, we are committed to treating our employees as partners. We do this by investing heavily in the following pillars:

Contact us

Fill out the form and we will contact you shortly.

Naam
Privacy Policy 
Continue reading
  • Participatory corporate culture. At our company, everyone is closely involved in the day-to-day operations. Everyone’s input is valued and taken into consideration when making decisions. You’re not just a number to us—your input will be greatly appreciated. Together, we know more! In addition to project work, you’ll also have the opportunity to gain business insights.
  • Personal growth. Our company is home to experienced QA experts and QPs across various fields. We see it as our responsibility to ensure that young people have the opportunity to learn from them—and vice versa. In addition, everyone has the opportunity to take external training courses based on their own interests. An annual training budget is allocated for this purpose for each consultant.
  • Challenge. As a consultant, you’ll work with various companies and on different assignments. During each project, you’ll gain new knowledge and insights. This is a huge advantage, especially at the start of your career when you’re not yet sure which direction you want to take. By the way, we always select new projects in consultation with you. We’re committed to focusing on projects that require specialized expertise, so there’s no shortage of challenges!
  • Career Opportunities. We’re a young company that was founded just two years ago. However, we still have plenty of ambition and ideas to further expand our business. With us, you’ll have a unique opportunity to help build this from the very beginning and reap the rewards! Or who knows—maybe you have a great business idea of your own that we can bring to life together?
  • Transparent compensation package. The days when everyone’s compensation package was treated like the biggest state secret are over. We’re committed to offering a transparent compensation package based on experience and performance. Everyone is treated equally based on clearly defined criteria. As a leading firm, we pay our consultants above-average salaries—which is, of course, a nice bonus ;). This is reflected not only in the gross salary but also in an attractive package of fringe benefits.

Are you interested in discussing the specific opportunities? Then get in touch with us soon—and who knows, you might just become our new colleague!

Your partner in quality, safety, and compliance

The life sciences sector requires specialized knowledge and reliable guidance. Thanks to our extensive expertise, we help organizations comply with laws and regulations, ensure quality, and continue to innovate with confidence.

Related Services

Medical Team Performing Surgical Operation in Bright Modern Operating Room

Quality Management System (QMS)

Program and Project Management

Related Articles

10 Jul 2026

Project Management

In the complex and highly regulated world of the pharmaceutical industry, project management plays a pivotal role to bring life-saving medications and treatments to the market. From drug discovery to clinical trials and regulatory approval, effective project management is essential for managing timelines, resources, and compliance. Let’s dive in some practical tips and tricks specifically for navigating the complexities of project management in the pharmaceutical sector.

10 Jul 2026

Potential Pitfalls in an MES Project

Just as every project has its pitfalls, the same is true for a Manufacturing Execution System (MES) implementation project. Implementing electronic batch records is no easy task. That’s why, in the blog below, we’ll share a few pitfalls so you can prepare for a successful implementation within your company.

10 Jul 2026

Streamlining Post-Marketing Surveillance with IMDRF Coding

Since the implementation of the Medical Device Regulation (MDR) in Europe, companies have had to maintain and execute a post-marketing surveillance (PMS) procedure. This systematic process involves collecting and analysing data on the performance and safety of medical devices after they have been released to the market. The primary goal is to help manufacturers identify and address potential issues that may arise during actual use, monitor the market for known risks, and identify new risks.

10 Jul 2026

ISO 9001:2015 in Life Sciences Industry

In the life sciences industry, maintaining high quality standards is critical not only to the success and sustainability of organizations but also to patient safety and compliance. ISO 9001:2015, part of the ISO 9000 family, provides a robust framework for quality management systems (QMS) that can be used in organizations in the life sciences, including pharmaceutical, natural technology, including medical devices. This article examines the key features of ISO 9001:2015, its benefits, implementation methods, potential pitfalls, and impact in the life sciences.

10 Jul 2026

The Role of a CQV Expert in the Cold Chain Division of a Pharmaceutical Company

In the pharmaceutical industry, product quality is of vital importance. This is particularly true for medicinal products that are sensitive to temperature fluctuations, such as vaccines, biologics, and certain medications that must be stored and transported in a controlled environment. Within this process, the CQV (Commissioning, Qualification, and Validation) expert plays a crucial role, especially within the cold chain division, which is responsible for monitoring product quality during the transport and storage of these temperature-sensitive products. This blog outlines the various aspects a CQV expert must consider in this context.

10 Jul 2026

Radiopharmaceutical & Selective Internal Radiation Treatments: Overcoming Challenges and Embracing Future Opportunities

Radiopharmaceutical and selective internal radiation treatments have emerged as a transformative force in the pharmaceutical industry, offering precision, personalized therapies for patients with conditions such as cancer and other serious diseases.

10 Jul 2026

Implementation of the European Clinical Trial Regulation (EU-CTR)

By the end of this month (31st of January 2025), the final deadline is reached in the transition period for the implementation of the European Clinical Trial Regulation (EU-CTR). What is it and what is the difference with the previous European Clinical Trial Directive (EU-CTD)?